Table 4.
Summary of prior findings regarding factors associated with non-alcoholic fatty pancreas
Study | Sample size (FP:NP) | Method of detection | Associated factors | No correlation |
---|---|---|---|---|
Al-Haddad M, et al.[11] |
120 (60/60) |
EUS |
BMI, hepatic steatosis, alcohol |
|
Sepe PS, et al.[10] |
230 (64/166) |
EUS |
BMI, fatty liver, hyperlipidemia, MetS |
DM, pancreatits, pancreatic cancer, age, alcohol, tobacco amylase |
Choi CW, et al.[17]. |
284 (174/110) |
EUS |
Hepatic steatosis, HTN, Alcohol, tobacco male, age>60 |
|
Lee JS, et al.[13] |
293 (180/113) |
Trans-abd ominal US |
IR, VAT, ALT, MetS |
FBG, LDL-C |
Heni M et al.[12] |
51 |
MRI |
BMI, VAT, waist circumference |
Fatty liver |
Lingvay I, et al. [14] |
79 |
MRI |
BMI, hyperglycemia |
|
Sijens PE, et al.[15] |
36 |
MRI |
BMI, liver fat |
|
Tushuizen ME, et al.[16] | 36 (12/24) | MRI | Beta-cell dysfunction | Fatty liver, VAT |
IR, insulin resistance; DM, diabetes mellitus; MetS, metabolic syndrome; ALT, alanine aminotransferase; HTN, hypertension; VAT, visceral adipose tissue; FP, fatty pancreas; NP, normal pancreas; EUS, endoscopic ultrasonography; US, ultrasonography; FBG, fasting blood glucose; LDL-C, low density lipoprotein-cholesterol.